Lymphangioleiomyomatosis: A national registry for a rare disease

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 1, 2006, Pages 2-4

  Tattersfield, Anne E ^a   Glassberg, Marilyn K ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA BASE; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; HUMAN; IMAGING; LUNG DISEASE; LYMPHANGIOLEIOMYOMATOSIS; MEDICAL RESEARCH; PATIENT; PNEUMOTHORAX; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REGISTER;

ADULT; HUMANS; LUNG DISEASES; LYMPHANGIOLEIOMYOMATOSIS; RARE DISEASES; REGISTRIES; UNITED STATES;

EID: 30344467219     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.2509010     Document Type: Editorial

References (16)

1. Taylor JR, Ryu J, Colby T, Raffin T. Lymphangioleiomyomatosis: clinical course in 32 patients. N Engl J Med 1990;323:1254-1260.
2. Kitaichi M, Nishimura K, Itoh H, Izumi T. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995;151:527-533.
3. Bernstein SM, Newekk JD, Adamczyk D, Mortenson RL, King TE, Lynch DA. How common are renal angiomyolipomas with pulmonary lymphangiomyomatosis? Am J Respir Crit Care Med 1995;152:2138-2143.
4. Blute MJ. How common are renal angiomyolipomas in patients with pulmonary lymphangioleiomyomatosis [letter]? Am J Respir Crit Care Med 1996;154:1580.
5. Johnson SR, Tattersfield AE. Decline in lung function in lymphangioleiomyomatosis. Relation to menopause and progesterone treatment. Am J Respir Crit Care Med 1999;160:628-633.
6. Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 2000;75:591-594.
7. Moss J, Avila NA, Barnes PM, Litzenberger RA, Bechtle JM, Brooks PG, Hedin CJ, Hunsberger S, Kristof AS. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001;163:669-671.
8. Smolarek TA, Wessner LL, McCormack FX, Mylet JC, Menon AG, Henske EP. Evidence that lymphangioleiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangioleiomyomatosis. Am J Hum Genet 1998;62:810-815.
9. Goncharova EA, Goncharov DA, Esterhaus A, Hunter DS, Glassberg MK, Yeung RS, Panettieri RA, Krymskaya V. Tuberin regulates p70S6kinase activation and ribosomal protein S6 phosphorylation: a role for TSC2 suppressor gene in pulmonary lymphangioleiomyomatosis. J Biol Chem 2002;277:30958-30967.
10. Glassberg MK. Lymphangioleiomyomatosis. Clin Chest Med 2004;25:573-582.
11. Ryu JH, Moss J, Beck GJ, Lee J-C, Brown KK, Chapman JT, Finlay GA, Olson EJ, Ruoss SJ, Maurer JR, et al; LAM Registry Group. The NHLBI Lymphangioleiomyomatosis Registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006;173:105-111.
12. Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, Ferrans VJ,Moss J. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999;115:1041-1052.
13. Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000;55:1052-1057.
14. Taveira-DaSilva AM, Stylianou MP, Hedin CJ, Hathaway O, Moss J. Bone mineral density in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2005;171:61-67.
15. Taveira-DaSilva AM, Stylianou MP, Hedin CJ, Kristof AS, Avila NA, Rabel A, Travis WD, Moss J. Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2003;168:1427-1431.
16. Moss J, DeCastro R, Patronas NJ, Taveira-DaSilva A. Meningiomas in lymphangioleiomyomatosis. JAMA 2002;286:1879-1881.